Data Quality and Technology in Clinical Trials 2016 2026 2027 (58170)

Become a data company: Work with pharma’s leaders to design the analytics-driven organization of the future
Maximize data quality: Enhance your trial rate of success with the perfect protocol design
Focus on what matters: Achieve a structured risk identification, analysis, and measurement and successfully transition to Risk Based Monitoring
Harness the right analytics: Translate and adopt the hidden message behind your data
Why Attend?
Align your objectives with your sites: Collaborate with key stakeholders and optimize the information exchange
An Agenda that addresses what really matters: The unique compelling document is an objective reflection of months of research with +100 top pharma executives
First clinical meeting chaired by the FDA: Hear directly from regulators on various topics such as new types patient data and when does the generated insight cross regulatory lines
Audience will make the impact in the industry: +150 pharma decision makers attending the meeting will bring back and implement exclusive insight to their organization
Each topic will be addressed by the industry’s thought leader: Handpicked 20+ industry leading speakers including C-Suite, VP and Director level experts to share their experiences so you can design better trials using the latest technologies, analytics and techniques